Iceland vs Sao Tome and Principe: Previously treated cases tested for RR-/MDR-TB
Iceland
100.0%
in 2022
Sao Tome and Principe
100.0%
in 2024
Iceland rank
1st
Sao Tome and Principe rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Iceland
- Sao Tome and Principe
How they compare
Iceland currently reports 100.0% against 100.0% in Sao Tome and Principe, a difference of 0.0%.
The two have swapped places 2 times across 5 shared years of data; in 2011 it was Sao Tome and Principe ahead.
Iceland ranks 1st and Sao Tome and Principe ranks 1st of 180 countries.
Iceland has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Iceland | Sao Tome and Principe | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 62.5% | 21.8% | 40.8% | Iceland |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Iceland or Sao Tome and Principe?
- Iceland, at 100.0% against 100.0% in Sao Tome and Principe as of 2022.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Iceland and Sao Tome and Principe?
- 0.0%, with Iceland ahead.
- How many years of comparable data are there for Iceland and Sao Tome and Principe?
- 5 years are reported by both, from 2011 to 2022.
- How do Iceland and Sao Tome and Principe rank globally for previously treated cases tested for rr-/mdr-tb?
- Iceland ranks 1st and Sao Tome and Principe ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.